PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 5, 1999, Pages 1361-1365

  Morange, P E ^a   Alessi, M C ^a   Verdier, M ^a   Casanova, D ^b   Magalon, G ^b   Juhan Vague, I ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Adipose tissue; Humans; PAI 1; TGF ; TNF

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINOPLASTY; ADIPOSE TISSUE; ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; MALE; OBESITY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032957071     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.5.1361     Document Type: Article

References (37)

1. Desprès JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S. Lupien PJ. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996;334:952-957.
2. Juhan-Vague I, Alessi MC, Vague P. Increased plasma plasminogen activator inhibitor 1 levels: a possible link between insulin resistance and atherothrombosis. Diabetologia. 1991;34:457-462.
3. Juhan-Vague I, Pyke S, Alessi MC, Jespersen J, Haverkate F, Thompson SG. Fibrinolytic factor and the risk of myocardial infarction or sudden death in patients with angina pectoris. Circulation. 1996;94:2057-2063.
4. Sylvan A, Rutergard JN, Janunger KG, Sjölund B, Nilsson TK. Normal plasminogen activator inhibitor levels at long-term follow-up after jejuno-ileal bypass in morbidly obese individuals. Metabolism. 1992;41: 1370-1372.
5. Folsom AR, Qamhieh HT, Wing RR, Jeffrey RW, Stinson VL, Kuller LH, Wu KK. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults. Arterioscler Thromb. 1993;13:162-169.
6. Primrose JN, Davies JA, Prentice CRM, Hughes R, Johnston D. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor 1 activity after surgical treatment of morbid obesity. Thromb Haemost. 1992;68:396-399.
7. McGill JB, Schneider DJ, Arfken CL, Lucore CL, Sobel BE. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients. Diabetes. 1994;43:104-109.
8. Alessi MC, Parrot G, Guenoun E, Scelles V, Vague P, Juhan-Vague I. Relation between plasma PAI activity and adipsin levels. Thromb Haemost. 1995;74:1200-1202.
9. Sawdey S, Loskutoff DJ. Regulation of murine type 1 plasminogen activator inhibitor (PAI-1) gene expression in vivo: tissue specificity and induction by lipopolysaccharide, tumor necrosis factor α and transforming growth factor β. J Clin Invest. 1991;88:1346-1353.
10. Samad F, Yamamoto K, Loskutoff DJ. Distribution and regulation of plasminogen activator inhibitor 1 in murine adipose tissue in vivo. J Clin Invest. 1996;971:37-46.
11. Lundgren CH, Brown SL, Nordt TD, Sobel BE, Fujii S. Elaboration of type 1 plasminogen activator inhibitor from adipocytes: a potential pathogenic link between obesity and cardiovascular disease. Circulation. 1996;93:106-110.
12. Cigolini M, Targher G, Bergamo Andreis IA, Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol. 1996;16: 368-374.
13. Shimomura I, Funahashi T, Takahashi M, Maeda k, Kotani K, Nakamura T, Yamashita S, Miura M, Fukuda Y, Takemura K, Tokunaga K, Matsuzawa Y. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med. 1996;2:800-803.
14. Janand-Delenne B, Chagnaud C, Raccah D, Alessi MC, Juhan-Vague I, Vague P. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women. Int J Obes Relat Metab Disord. 1998;22: 312-317.
15. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue. Diabetes. 1997;46:860-867.
16. Eriksson P, Reynisdottir S, Lönnqvist F, Stemme V, Hamsten A, Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia. 1998;41:65-71.
17. Fujii S, Hopkins WE, Sobel BE. Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis. Circulation. 1991;83:645-651.
18. Reilly CF, McFall RC. Platelet derived growth factor and transforming growth factor-β regulate plasminogen activator inhibitor-1 in vascular smooth muscle cells. J Biol Chem. 1991;266:9419-9427.
19. Fujii S, Lucore CL, Hopkins WE, Billadello JJ, Sobel BE. Potential attenuation of fibrinolysis by growth factors released from platelets and their pharmacologic implications. Am J Cardiol. 1989;63:1505-1511.
20. Hotamisligil GS, Spiegelman BM. Tumor necrosis factor: a key component of the obesity-diabetes link. Diabetes. 1994;43:1271-1278.
21. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 (PAI-1) in biological fluids with a murine monoclonal antibody, based on enzyme-linked immunoadsorbent assay. Blood. 1988;71:220-225.
22. Samad F, Loskutoff DJ. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med. 1996;2:568-582.
23. Vague P, Juhan-Vague I, Chabert V, Alessi MC, Atlan C. Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women. Metabolism. 1989;38:913-915.
24. Landin K, Stigendal L, Eriksson E, Krotiewski M, Risberg B, Tengborn L, Smith U. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1. Metabolism. 1990;39:1044-1048.
25. Alessi MC, Juhan-Vague I, Kooistra T, Declerck PJ, Collen D. Insulin stimulates the synthesis of plasminogen activator 1 by the human hepatocellular cell line Hep G2. Thromb Haemost. 1988;60:491-494.
26. Kooistra T, Bosma PJ, Tons HAM, Van Den Berg AP, Meyer P, Princen HMG. Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured hepatocytes. Thromb Haemost. 1989; 62:723-728.
27. Schneider DJ, Sobel BE. Augmentation of synthesis of plasminogen activator type 1 by insulin and insulin-like growth factor type 1: implications for vascular disease by hyperinsulinemic states. Proc Natl Acad Sci U S A. 1991;88:9959-9963.
28. Anfosso F, Chomiki N, Alessi MC, Vague P, Juhan-Vague I. Plasminogen activator inhibitor 1 synthesis in the human hepatoma cell line Hep G2: metformin inhibits the stimulating effect of insulin. J Clin Invest. 1993;91:2185-2193.
29. Alessi MC, Anfosso F, Henry M, Peiretti F, Nalbone G, Juhan-Vague I. Up-regulation of PAI-1 synthesis by insulin and proinsulin in Hep G2 cells but not in endothelial cells. Fibrinolysis. 1995;9:237-242.
30. Hotamisligil GS, Shargill NS, Spiegelman BS. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science. 1993;259:87-91.
31. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature. 1997;389:610-614.
32. Ventre J, Doebber T, Wu M, MacNaul K, Stevens K, Pasparakis M, Kollias G, Moller DE. Targeted disruption of the tumor necrosis factor-α gene: metabolic consequences in obese and non obese mice. Diabetes. 1997;46:1526-1531.
33. Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA. The expression of TNF-α by human muscle: relationship to insulin resistance. J Clin Invest. 1996;97:1111-1116.
34. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest. 1995;95:2409-2415.
35. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol. 1987;105:1039-1045.
36. Samad F, Yamamoto K, Pandey M, Loskutoff DJ. Elevated expression of transforming growth factor-β in adipose tissue from obese mice. Mol Med. 1997;3:37-48.
37. Loskutoff DJ, Samad F. The adipocyte and hemostatic balance in obesity studies of PAI-1. Arterioscler Thromb Vasc Biol. 1998;18:1-6.